SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Emmaus Life Sciences, Inc. – ‘10-Q’ for 6/30/17

On:  Monday, 8/14/17, at 5:27pm ET   ·   For:  6/30/17   ·   Accession #:  1615774-17-4413   ·   File #:  1-35527

Previous ‘10-Q’:  ‘10-Q’ on 5/15/17 for 3/31/17   ·   Next:  ‘10-Q’ on 2/20/18 for 12/31/17   ·   Latest:  ‘10-Q’ on 11/14/23 for 9/30/23   ·   2 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 8/14/17  Emmaus Life Sciences, Inc.        10-Q        6/30/17   52:5.4M                                   S2 Filings LLC/FA

Quarterly Report   —   Form 10-Q   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    473K 
 2: EX-3.1      Articles of Incorporation/Organization or Bylaws    HTML    123K 
 3: EX-4.9      Instrument Defining the Rights of Security Holders  HTML    137K 
 4: EX-10.30    Material Contract                                   HTML     35K 
 5: EX-31.1     Certification -- §302 - SOA'02                      HTML     20K 
 6: EX-31.2     Certification -- §302 - SOA'02                      HTML     20K 
 7: EX-32.1     Certification -- §906 - SOA'02                      HTML     17K 
14: R1          Document and Entity Information                     HTML     42K 
15: R2          Unaudited Condensed Consolidated Statements of      HTML     68K 
                Operations                                                       
16: R3          Unaudited Condensed Consolidated Balance Sheets     HTML    101K 
17: R4          Unaudited Condensed Consolidated Balance Sheets     HTML     38K 
                (Parenthetical)                                                  
18: R5          Unaudited Condensed Consolidated Statements of      HTML    103K 
                Cash Flows                                                       
19: R6          Unaudited Condensed Consolidated Statements of      HTML     57K 
                Stockholders' Deficit                                            
20: R7          Nature of Operations                                HTML     44K 
21: R8          Summary of Significant Accounting Policies          HTML     62K 
22: R9          Stockholders' Equity                                HTML    151K 
23: R10         Prior Year Revision                                 HTML     35K 
24: R11         Related Party Transactions                          HTML     55K 
25: R12         Loss Per Share                                      HTML     42K 
26: R13         Commitments and Contingent Liabilities              HTML     36K 
27: R14         Subsequent Events                                   HTML     30K 
28: R15         Summary of Significant Accounting Policies          HTML    122K 
                (Policies)                                                       
29: R16         Stockholders' Equity (Tables)                       HTML    113K 
30: R17         Prior Year Revision (Tables)                        HTML     32K 
31: R18         Related Party Transactions (Tables)                 HTML     36K 
32: R19         Loss Per Share (Tables)                             HTML     41K 
33: R20         Commitments and Contingent Liabilities (Tables)     HTML     30K 
34: R21         Nature of Operations (Details Narrative)            HTML     90K 
35: R22         Summary of Significant Accounting Policies          HTML     72K 
                (Details Narrative)                                              
36: R23         Stockholders' Equity (Details)                      HTML     25K 
37: R24         Stockholders' Equity (Details 1)                    HTML     39K 
38: R25         Stockholders' Equity (Details 2)                    HTML    115K 
39: R26         Stockholders' Equity (Details 3)                    HTML     39K 
40: R27         Stockholders' Equity (Details 4)                    HTML     46K 
41: R28         Stockholders' Equity (Details Narrative)            HTML    491K 
42: R29         Stockholders' Equity (Details Narrative 1)          HTML     46K 
43: R30         Prior Year Revision (Details)                       HTML     25K 
44: R31         Related Party Transactions (Details)                HTML     50K 
45: R32         Related Party Transactions (Details Narrative)      HTML    119K 
46: R33         Loss Per Share (Details)                            HTML     36K 
47: R34         Commitments and Contingent Liabilities (Details)    HTML     52K 
48: R35         Commitments and Contingent Liabilities (Details     HTML     51K 
                Narrative)                                                       
49: R36         Subsequent Events (Details Narrative)               HTML     89K 
51: XML         IDEA XML File -- Filing Summary                      XML     84K 
50: EXCEL       IDEA Workbook of Financial Reports                  XLSX     79K 
 8: EX-101.INS  XBRL Instance -- myan-20170630                       XML   1.58M 
10: EX-101.CAL  XBRL Calculations -- myan-20170630_cal               XML    120K 
11: EX-101.DEF  XBRL Definitions -- myan-20170630_def                XML    549K 
12: EX-101.LAB  XBRL Labels -- myan-20170630_lab                     XML    924K 
13: EX-101.PRE  XBRL Presentations -- myan-20170630_pre              XML    731K 
 9: EX-101.SCH  XBRL Schema -- myan-20170630                         XSD    131K 
52: ZIP         XBRL Zipped Folder -- 0001615774-17-004413-xbrl      Zip    131K 




        
Filing Submission 0001615774-17-004413 – SGML Text

Original SGML Text submitted by:  S2 Filings LLC/FA  (as Filing Agent) 

To view the SGML, please refresh
Refresh emoji
this page.


Top

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Sat., Apr. 27, 5:42:18.2pm ET